Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Design Therapeutics, Inc. (DSGN)
USD13.37
-0.30 (-2.18%)
US NASDAQ Healthcare Biotechnology
Address
6005 Hidden Valley Road 92011
Carlsbad, CA, US
Carlsbad, CA, US
CEO
Pratik Shah
Website
designtx.com
IPO
2021-03-29
CIK 1807120 ISIN US25056L1035
Description
Design Therapeutics, Inc. is a biopharmaceutical company in the preclinical phase that focuses on creating treatments for genetic conditions stemming from nucleotide repeat expansions. Its current pipeline targets Friedreich's Ataxia (FA), a severe, progressive, monogenic, and autosomal recessive disease. FA primarily impairs mitochondrial function across various organ systems, resulting in neurological, cardiac, and metabolic complications. Another significant area of development is Myotonic Dystrophy Type-1 (DM1). This is a progressive, dominantly inherited monogenic neuromuscular illness that impacts skeletal muscle, the heart, brain, and other bodily systems. Beyond these, the company is advancing its GeneTAC product candidate platform to address an array of other monogenic conditions caused by nucleotide repeat expansions. These include Fragile X syndrome, various spinocerebellar ataxias, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, Huntington's disease, and spinobulbar muscular atrophy. Established in 2017, Design Therapeutics, Inc. maintains its headquarters in Carlsbad, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD13.37
-0.30 (-2.18%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
889.4K
Beta
1.66
Float Shares
35.36M
Free Float %
56.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.42% | -4.64% | -22.94% | +0.38% | +11.61% | +11.73% | +180.97% | +74.96% | -59.88% | -74.74% | -74.74% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
13.37
Low
14.00
+4.7%
Consensus
17.50
+30.9%
Median
17.50
+30.9%
High
21.00
+57.0%
DCF (Unlevered)
0.27
-98.0%
DCF (Levered)
0.28
-97.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 5 | +1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
21.00
+57.0%
|
| Last Quarter | 2 |
20.50
+53.3%
|
| Last Year | 5 |
17.60
+31.6%
|
| All Time | 10 |
18.90
+41.3%
|
Quality scores
Altman Z-Score
29.86
Safe zone
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-38.6% Q1'26: +6.5% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +3,873.4% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+1.3% ★ Q1'26: +8.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.01× Q1'26: -0.03× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 5 EPS Ana. |
Dec 2027 7 Rev. Ana. 5 EPS Ana. |
Dec 2028 6 Rev. Ana. 5 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
est: 48.53M (-100.0%)
|
117.33M
117.33M – 117.33M
+141.8% YoY
|
204.78M
204.78M – 204.78M
+74.5% YoY
|
8.40M
8.40M – 8.40M
-95.9% YoY
|
72.09M
72.09M – 72.09M
+758.2% YoY
|
235.57M
235.57M – 235.57M
+226.8% YoY
|
| EBITDA |
-48.99M
|
-78.85M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-49.59M
|
-79.47M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-49.59M
est: -50.93M (+2.6%)
|
-69.79M
est: -74.36M (+6.1%)
|
-85.49M
-93.45M – -67.08M
-15.0% YoY
|
-94.60M
-112.53M – -76.68M
-10.7% YoY
|
-109.43M
-138.13M – -80.73M
-15.7% YoY
|
-86.28M
-86.28M – -86.28M
+21.2% YoY
|
-2.96M
-2.96M – -2.96M
+96.6% YoY
|
| SGA |
18.03M
|
20.34M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-0.88
est: -0.90 (+2.2%)
|
-1.22
est: -1.30 (+6.3%)
|
-1.36
-1.63 – -1.17
-4.5% YoY
|
-1.64
-1.96 – -1.34
-20.3% YoY
|
-1.95
-2.41 – -1.41
-19.3% YoY
|
-1.51
-1.51 – -1.51
+22.9% YoY
|
-0.05
-0.05 – -0.05
+96.6% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-04 | Oppenheimer | Outperform | Outperform | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-19 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-18 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-15 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-14 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-13 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-12 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-11 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-53.90M
OE per share TTM
-0.92
Owner's Yield
-8.37%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
2,569,065.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
124
Total invested
404.11M
Insider transactions (90d)
0
Beneficial owners (>5%)
22
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | of 5 Pages | 7.67M | 13.80% | — | — | 7.67M | — | IN | — | 2022-02-09 | ↗ |
| 2 | Simeon George | 5.64M | 10.50% | 15.0K | 5.63M | 15.0K | 5.63M | IN | — | 2021-04-09 | ↗ |
| 3 | LLC | 5.63M | 10.50% | — | 5.63M | — | 5.63M | HC | — | 2021-04-09 | ↗ |
| 4 | LP | 5.63M | 10.50% | 5.63M | — | 5.63M | — | PN | — | 2021-04-09 | ↗ |
| 5 | Bihua Chen | 5.11M | 9.20% | — | 5.11M | — | — | IN | Cayman Islands | 2021-04-09 | ↗ |
| 6 | Cormorant Asset Management, LP | 5.11M | 9.20% | — | 5.11M | — | — | PN | Cayman Islands | 2021-04-09 | ↗ |
| 7 | Jason Howerton | 3.83M | 6.90% | — | 3.83M | — | 3.83M | IN | United States | 2022-02-09 | ↗ |
| 8 | Light Irrevocable Trust #1 dated April 22, 2019 | 3.83M | 6.90% | — | 3.83M | — | 3.83M | OO | United States | 2022-02-09 | ↗ |
| 9 | (1) BlackRock, Inc. | 3.51M | 6.30% | 3.46M | — | 3.51M | — | HC | Delaware | 2023-02-03 | ↗ |
| 10 | STATE STREET CORPORATION | 3.04M | 5.43% | — | 3.00M | — | 3.04M | HC | BOSTON, MASSACHUSETTS | 2023-02-08 | ↗ |
| 11 | Peter Kolchinsky | 2.97M | 5.32% | — | 2.97M | — | — | HC, IN | United States of America | 2022-10-13 | ↗ |
| 12 | RA Capital Healthcare Fund, L.P. | 2.97M | 5.32% | — | 2.97M | — | — | PN | Delaware | 2022-10-13 | ↗ |
| 13 | RA Capital Management, L.P. | 2.97M | 5.32% | — | 2.97M | — | — | IA, PN | Delaware | 2022-10-13 | ↗ |
| 14 | Rajeev Shah | 2.97M | 5.32% | — | 2.97M | — | — | HC, IN | United States of America | 2022-10-13 | ↗ |
| 15 | Cormorant Private Healthcare Fund II, LP | 2.34M | 4.20% | — | 2.34M | — | — | PN | Cayman Islands | 2021-04-09 | ↗ |
| 16 | Cormorant Private Healthcare GP II, LLC | 2.34M | 4.20% | — | 2.34M | — | — | OO | Cayman Islands | 2021-04-09 | ↗ |
| 17 | Cormorant Global Healthcare GP, LLC | 1.60M | 2.88% | — | 1.60M | — | — | OO | Cayman Islands | 2021-04-09 | ↗ |
| 18 | Cormorant Global Healthcare Master Fund, LP | 1.60M | 2.88% | — | 1.60M | — | — | PN | Cayman Islands | 2021-04-09 | ↗ |
| 19 | Cormorant Private Healthcare Fund III, LP | 1.08M | 1.95% | — | 1.08M | — | — | PN | Cayman Islands | 2021-04-09 | ↗ |
| 20 | Cormorant Private Healthcare GP III, LLC | 1.08M | 1.95% | — | 1.08M | — | — | OO | Cayman Islands | 2021-04-09 | ↗ |
| 21 | 2. | 10.00 | 4.60% | — | 2.58M | — | — | IA, HC, OO | Delaware | 2023-04-03 | ↗ |
| 22 | Citadel Advisors Holdings LP | 6.00 | 4.40% | — | 2.71M | — | 2.71M | HC, PN | U.S. Citizen | 2022-12-22 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
124
+6 vs prev Q
New positions
21
Closed positions
14
Increased
78
Reduced
28
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 207.9K +207.9K (+100.0%) | 1.95B +2.0B (+100.0%) | 0.37% +0.365 pp | 0.58% +0.576 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 2 | SR ONE CAPITAL MANAGEMENT, LP | 6.53M +— (+0.0%) | 61.22M +12.1M (+24.6%) | 11.46% -0.019 pp | 8.67% +1.559 pp | USD19.87 -52.8% | 17 qtrs — |
| 3 | POINT72 ASSET MANAGEMENT, L.P. | 5.37M +2.0M (+60.8%) | 50.39M +25.2M (+100.3%) | 9.43% +3.558 pp | 0.06% +0.014 pp | USD7.24 +29.6% | 12 qtrs — |
| 4 | LOGOS GLOBAL MANAGEMENT LP | 2.50M -1.2M (-31.6%) | 23.45M -4.1M (-14.8%) | 4.39% -2.038 pp | 1.42% -1.050 pp | USD17.48 -46.3% | 20 qtrs — |
| 5 | BAKER BROS. ADVISORS LP | 2.23M +520.2K (+30.4%) | 20.95M +8.0M (+62.4%) | 3.92% +0.909 pp | 0.12% +0.029 pp | USD10.25 -8.5% | 20 qtrs — |
| 6 | BLACKROCK, INC. | 2.12M +72.8K (+3.6%) | 19.86M +4.5M (+29.0%) | 3.72% +0.122 pp | 0.00% +0.000 pp | USD5.58 +68.1% | 6 qtrs — |
| 7 | VANGUARD GROUP INC | 1.63M +187.2K (+13.0%) | 15.30M +4.4M (+40.7%) | 2.86% +0.325 pp | 0.00% +0.000 pp | USD14.33 -34.5% | 20 qtrs — |
| 8 | VIVO CAPITAL, LLC | 1.61M +1.6M (+100.0%) | 15.13M +15.1M (+100.0%) | 2.83% +2.832 pp | 0.98% +0.978 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 9 | ALMITAS CAPITAL LLC | 1.53M +— (+0.0%) | 14.36M +2.8M (+24.6%) | 2.69% -0.004 pp | 3.16% +0.523 pp | USD3.00 +212.7% | 9 qtrs — |
| 10 | RA CAPITAL MANAGEMENT, L.P. | 1.46M +985.7K (+207.2%) | 13.71M +10.1M (+282.7%) | 2.57% +1.729 pp | 0.14% +0.096 pp | USD8.78 +6.8% | 2 qtrs — |
| 11 | DRIEHAUS CAPITAL MANAGEMENT LLC | 1.18M +103.6K (+9.6%) | 11.07M +3.0M (+36.6%) | 2.07% +0.179 pp | 0.08% +0.017 pp | USD5.80 +61.7% | 5 qtrs — |
| 12 | WOODLINE PARTNERS LP | 944.0K +331.3K (+54.1%) | 8.86M +4.2M (+91.9%) | 1.66% +0.580 pp | 0.03% +0.013 pp | USD5.74 +63.4% | 4 qtrs — |
| 13 | KYNAM CAPITAL MANAGEMENT, LP | 784.6K -245.0K (-23.8%) | 7.36M -393.1K (-5.1%) | 1.38% -0.433 pp | 0.47% -0.107 pp | USD3.80 +146.8% | 4 qtrs — |
| 14 | FMR LLC | 771.3K +30.4K (+4.1%) | 7.23M +1.7M (+29.7%) | 1.35% +0.051 pp | 0.00% +0.000 pp | USD7.20 +30.3% | 20 qtrs — |
| 15 | MORGAN STANLEY | 702.3K +526.3K (+299.1%) | 6.59M +5.3M (+397.1%) | 1.23% +0.924 pp | 0.00% +0.000 pp | USD8.19 +14.5% | 19 qtrs — |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 679.6K -16.0K (-2.3%) | 6.38M +1.1M (+21.7%) | 1.19% -0.030 pp | 0.00% +0.000 pp | USD15.27 -38.6% | 20 qtrs — |
| 17 | STATE STREET CORP | 647.6K +13.2K (+2.1%) | 6.07M +1.3M (+27.2%) | 1.14% +0.022 pp | 0.00% +0.000 pp | USD10.60 -11.5% | 19 qtrs — |
| 18 | ACADIAN ASSET MANAGEMENT LLC | 612.8K -4.7K (-0.8%) | 5.74M +1.1M (+23.5%) | 1.08% -0.010 pp | 0.01% +0.001 pp | USD3.41 +175.1% | 9 qtrs — |
| 19 | FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 521.0K -1.4M (-73.3%) | 4.89M -9.8M (-66.8%) | 0.91% -2.521 pp | 0.13% -0.310 pp | USD4.10 +128.8% | 7 qtrs — |
| 20 | CAPTION MANAGEMENT, LLC | 500.0K +500.0K (+100.0%) | 4.69M +4.7M (+100.0%) | 0.88% +0.878 pp | 0.03% +0.032 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 21 | CITADEL ADVISORS LLC | 459.9K -94.1K (-17.0%) | 4.31M +141.8K (+3.4%) | 0.81% -0.167 pp | 0.00% +0.000 pp | USD12.24 -23.4% | 20 qtrs — |
| 22 | D. E. SHAW & CO., INC. | 438.9K +65.6K (+17.6%) | 4.12M +1.3M (+46.5%) | 0.77% +0.114 pp | 0.00% +0.001 pp | USD4.29 +118.6% | 12 qtrs — |
| 23 | INVESCO LTD. | 305.8K +291.2K (+1,995.8%) | 2.87M +2.8M (+2,510.7%) | 0.54% +0.511 pp | 0.00% +0.000 pp | USD9.20 +2.0% | 5 qtrs — |
| 24 | DIMENSIONAL FUND ADVISORS LP | 297.9K +18.1K (+6.5%) | 2.80M +690.1K (+32.8%) | 0.52% +0.031 pp | 0.00% +0.000 pp | USD6.13 +53.0% | 15 qtrs — |
| 25 | RENAISSANCE TECHNOLOGIES LLC | 287.1K +12.8K (+4.7%) | 2.69M +627.5K (+30.4%) | 0.50% +0.022 pp | 0.00% +0.002 pp | USD3.49 +168.8% | 12 qtrs — |
| 26 | NORTHERN TRUST CORP | 286.6K -10.0K (-3.4%) | 2.69M +455.2K (+20.4%) | 0.50% -0.018 pp | 0.00% +0.000 pp | USD14.04 -33.2% | 19 qtrs — |
| 27 | GOLDMAN SACHS GROUP INC | 270.7K +9.2K (+3.5%) | 2.54M +570.1K (+29.0%) | 0.48% +0.015 pp | 0.00% +0.000 pp | USD6.61 +41.9% | 20 qtrs — |
| 28 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 236.9K -11.1K (-4.5%) | 2.22M +354.8K (+19.0%) | 0.42% -0.020 pp | 0.00% +0.000 pp | USD13.72 -31.6% | 19 qtrs — |
| 29 | JANE STREET GROUP, LLC | 226.5K +108.7K (+92.2%) | 2.12M +1.2M (+139.5%) | 0.40% +0.191 pp | 0.00% +0.000 pp | USD7.89 +18.9% | 12 qtrs — |
| 30 | MARSHALL WACE, LLP | 225.5K +225.5K (+100.0%) | 2.12M +2.1M (+100.0%) | 0.40% +0.396 pp | 0.00% +0.002 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 31 | JACOBS LEVY EQUITY MANAGEMENT, INC | 194.6K +194.6K (+100.0%) | 1.83M +1.8M (+100.0%) | 0.34% +0.342 pp | 0.01% +0.007 pp | USD9.38 +0.0% | 11 qtrs — |
| 32 | ALGERT GLOBAL LLC | 187.8K +187.8K (+100.0%) | 1.76M +1.8M (+100.0%) | 0.33% +0.330 pp | 0.03% +0.028 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 33 | MILLENNIUM MANAGEMENT LLC | 180.9K +112.0K (+162.8%) | 1.70M +1.2M (+227.4%) | 0.32% +0.197 pp | 0.00% +0.001 pp | USD8.68 +8.1% | 14 qtrs — |
| 34 | AMERIPRISE FINANCIAL INC | 158.4K +158.4K (+100.0%) | 1.49M +1.5M (+100.0%) | 0.28% +0.278 pp | 0.00% +0.000 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 35 | ACUTA CAPITAL PARTNERS, LLC | 150.9K +150.9K (+100.0%) | 1.42M +1.4M (+100.0%) | 0.27% +0.265 pp | 0.96% +0.961 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 36 | NUVEEN, LLC | 125.3K -7.8K (-5.8%) | 1.17M +173.2K (+17.3%) | 0.22% -0.014 pp | 0.00% +0.000 pp | USD3.86 +143.0% | 4 qtrs — |
| 37 | RAYMOND JAMES FINANCIAL INC | 109.8K +109.8K (+100.0%) | 1.03M +1.0M (+100.0%) | 0.19% +0.193 pp | 0.00% +0.000 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 38 | DIADEMA PARTNERS LP | 100.3K +100.3K (+100.0%) | 941.0K +941.0K (+100.0%) | 0.18% +0.176 pp | 0.16% +0.162 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 39 | TREXQUANT INVESTMENT LP | 100.0K +100.0K (+100.0%) | 937.7K +937.7K (+100.0%) | 0.18% +0.176 pp | 0.01% +0.008 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 40 | BNP PARIBAS ARBITRAGE, SNC | 94.8K +89.7K (+1,747.4%) | 889.5K +850.8K (+2,201.3%) | 0.17% +0.158 pp | 0.00% +0.000 pp | USD9.20 +2.0% | 5 qtrs — |
| 41 | BARCLAYS PLC | 87.1K -9.6K (-9.9%) | 816.6K +296.7K (+57.1%) | 0.15% -0.017 pp | 0.00% +0.000 pp | USD4.07 +130.5% | 16 qtrs — |
| 42 | BANK OF NEW YORK MELLON CORP | 85.0K -2.5K (-2.9%) | 797.1K +138.4K (+21.0%) | 0.15% -0.005 pp | 0.00% +0.000 pp | USD17.85 -47.5% | 19 qtrs — |
| 43 | EAM INVESTORS, LLC | 78.9K +78.9K (+100.0%) | 740.5K +740.5K (+100.0%) | 0.14% +0.139 pp | 0.08% +0.083 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 44 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 78.5K -109.7K (-58.3%) | 736.3K -680.8K (-48.0%) | 0.14% -0.193 pp | 0.02% -0.015 pp | USD3.01 +211.6% | 10 qtrs — |
| 45 | LYNX1 CAPITAL MANAGEMENT LP | 69.5K +3.6K (+5.4%) | 652.1K +155.4K (+31.3%) | 0.12% +0.006 pp | 0.13% +0.031 pp | USD4.14 +126.6% | 4 qtrs — |
| 46 | PALUMBO WEALTH MANAGEMENT LLC | 69.4K +17.3K (+33.2%) | 650.8K +258.6K (+65.9%) | 0.12% +0.030 pp | 0.16% +0.035 pp | USD5.72 +64.0% | 8 qtrs — |
| 47 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 61.9K +47.8K (+341.1%) | 580.2K +474.6K (+449.4%) | 0.11% +0.084 pp | 0.00% +0.000 pp | USD8.58 +9.3% | 15 qtrs — |
| 48 | AMERICAN CENTURY COMPANIES INC | 57.8K +6.9K (+13.7%) | 542.1K +159.2K (+41.6%) | 0.10% +0.012 pp | 0.00% +0.000 pp | USD5.12 +83.2% | 7 qtrs — |
| 49 | CANADA PENSION PLAN INVESTMENT BOARD | 54.6K +54.6K (+100.0%) | 512.1K +512.1K (+100.0%) | 0.10% +0.096 pp | 0.00% +0.000 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 50 | SEI INVESTMENTS CO | 52.7K +52.7K (+100.0%) | 494.6K +494.6K (+100.0%) | 0.09% +0.093 pp | 0.00% +0.001 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 51 | STATE OF WISCONSIN INVESTMENT BOARD | 50.7K +23.6K (+87.2%) | 475.2K +271.4K (+133.2%) | 0.09% +0.041 pp | 0.00% +0.001 pp | USD6.37 +47.3% | 4 qtrs — |
| 52 | KENNEDY CAPITAL MANAGEMENT LLC | 50.0K +20.6K (+70.1%) | 469.2K +247.8K (+111.9%) | 0.09% +0.036 pp | 0.01% +0.005 pp | USD7.84 +19.6% | 5 qtrs — |
| 53 | ALPS ADVISORS INC | 46.8K +46.8K (+100.0%) | 438.7K +438.7K (+100.0%) | 0.08% +0.082 pp | 0.00% +0.003 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 54 | TWO SIGMA INVESTMENTS, LP | 46.2K -13.0K (-21.9%) | 433.7K -12.4K (-2.8%) | 0.08% -0.023 pp | 0.00% 0.000 pp | USD3.25 +188.6% | 13 qtrs — |
| 55 | SQUAREPOINT OPS LLC | 46.1K +46.1K (+100.0%) | 432.8K +432.8K (+100.0%) | 0.08% +0.081 pp | 0.00% +0.001 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 56 | ALLIANCEBERNSTEIN L.P. | 46.1K +— (+0.0%) | 432.6K +85.3K (+24.6%) | 0.08% 0.000 pp | 0.00% +0.000 pp | USD9.89 -5.2% | 15 qtrs — |
| 57 | PRUDENTIAL FINANCIAL INC | 42.7K -2.1K (-4.7%) | 400.6K +63.1K (+18.7%) | 0.08% -0.004 pp | 0.00% +0.000 pp | USD4.45 +110.8% | 11 qtrs — |
| 58 | XTX TOPCO LTD | 35.3K +23.4K (+197.3%) | 331.0K +241.6K (+270.3%) | 0.06% +0.041 pp | 0.01% +0.004 pp | USD8.76 +7.1% | 2 qtrs — |
| 59 | PERSISTENT ASSET PARTNERS LTD | 35.0K +35.0K (+100.0%) | 328.2K +328.2K (+100.0%) | 0.06% +0.061 pp | 0.15% +0.147 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 60 | RHUMBLINE ADVISERS | 34.8K -11.6K (-24.9%) | 326.2K -22.7K (-6.5%) | 0.06% -0.020 pp | 0.00% +0.000 pp | USD14.69 -36.1% | 18 qtrs — |
| 61 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 34.3K -700.0 (-2.0%) | 321.6K +58.2K (+22.1%) | 0.06% -0.001 pp | 0.02% +0.003 pp | USD7.08 +32.5% | 5 qtrs — |
| 62 | BANK OF AMERICA CORP /DE/ | 27.4K +3.5K (+14.8%) | 257.4K +77.4K (+43.0%) | 0.05% +0.006 pp | 0.00% +0.000 pp | USD6.85 +36.9% | 20 qtrs — |
| 63 | CI PRIVATE WEALTH, LLC | 27.0K +27.0K (+100.0%) | 252.9K +252.9K (+100.0%) | 0.05% +0.047 pp | 0.00% +0.000 pp | USD9.38 +0.0% | 8 qtrs — |
| 64 | WELLS FARGO & COMPANY/MN | 26.8K +8.5K (+46.2%) | 251.3K +113.3K (+82.2%) | 0.05% +0.015 pp | 0.00% +0.000 pp | USD6.40 +46.6% | 17 qtrs — |
| 65 | UBS GROUP AG | 25.5K +2.8K (+12.5%) | 239.5K +68.7K (+40.2%) | 0.04% +0.005 pp | 0.00% +0.000 pp | USD6.12 +53.3% | 13 qtrs — |
| 66 | TWO SIGMA ADVISERS, LP | 25.3K -15.2K (-37.5%) | 237.3K -67.7K (-22.2%) | 0.04% -0.027 pp | 0.00% 0.000 pp | USD3.08 +204.5% | 12 qtrs — |
| 67 | RUSSELL INVESTMENTS GROUP, LTD. | 25.2K +18.9K (+295.7%) | 236.7K +188.7K (+392.9%) | 0.04% +0.033 pp | 0.00% +0.000 pp | USD8.38 +11.9% | 15 qtrs — |
| 68 | STRS OHIO | 25.2K +2.6K (+11.5%) | 236.4K +66.2K (+38.9%) | 0.04% +0.005 pp | 0.00% +0.000 pp | USD3.17 +195.9% | 10 qtrs — |
| 69 | VIRTU FINANCIAL LLC | 22.7K +22.7K (+100.0%) | 212.0K +212.0K (+100.0%) | 0.04% +0.040 pp | 0.01% +0.008 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 70 | ALPHACENTRIC ADVISORS LLC | 20.3K +20.3K (+100.0%) | 190.1K +190.1K (+100.0%) | 0.04% +0.036 pp | 0.19% +0.189 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 71 | VELAN CAPITAL INVESTMENT MANAGEMENT LP | 20.0K +— (+0.0%) | 187.6K +37.0K (+24.6%) | 0.04% 0.000 pp | 0.11% -0.033 pp | USD3.71 +152.8% | 4 qtrs — |
| 72 | BAADER BANK AKTIENGESELLSCHAFT | 20.0K +20.0K (+100.0%) | 187.6K +187.6K (+100.0%) | 0.04% +0.035 pp | 0.01% +0.013 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 73 | PRICE T ROWE ASSOCIATES INC /MD/ | 15.7K -603.0 (-3.7%) | 148.0K +25.0K (+20.3%) | 0.03% -0.001 pp | 0.00% +0.000 pp | USD4.17 +124.9% | 8 qtrs — |
| 74 | DEUTSCHE BANK AG\ | 15.5K +15.5K (+100.0%) | 145.8K +145.8K (+100.0%) | 0.03% +0.027 pp | 0.00% +0.000 pp | USD9.38 +0.0% | 19 qtrs — |
| 75 | METLIFE INVESTMENT MANAGEMENT, LLC | 15.2K +4.9K (+47.8%) | 143.0K +65.3K (+84.1%) | 0.03% +0.009 pp | 0.00% +0.000 pp | USD8.13 +15.4% | 6 qtrs — |
| 76 | JPMORGAN CHASE & CO | 14.5K -8.8K (-37.8%) | 135.6K -39.3K (-22.5%) | 0.03% -0.016 pp | 0.00% +0.000 pp | USD6.73 +39.4% | 19 qtrs — |
| 77 | ENGINEERS GATE MANAGER LP | 14.0K +14.0K (+100.0%) | 131.4K +131.4K (+100.0%) | 0.02% +0.025 pp | 0.00% +0.002 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 78 | AQR CAPITAL MANAGEMENT LLC | 13.7K +66.0 (+0.5%) | 128.8K +25.9K (+25.2%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD4.86 +93.0% | 9 qtrs — |
| 79 | MARINER, LLC | 12.8K -3.3K (-20.3%) | 120.0K -1.1K (-0.9%) | 0.02% -0.006 pp | 0.00% +0.000 pp | USD4.10 +128.8% | 8 qtrs — |
| 80 | NISA INVESTMENT ADVISORS, LLC | 11.8K +— (+0.0%) | 110.9K +21.9K (+24.6%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD2.68 +250.0% | 10 qtrs — |
| 81 | AXQ CAPITAL, LP | 11.7K +11.7K (+100.0%) | 110.0K +110.0K (+100.0%) | 0.02% +0.021 pp | 0.02% +0.025 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 82 | TWO SIGMA SECURITIES, LLC | 11.4K +11.4K (+100.0%) | 106.9K +106.9K (+100.0%) | 0.02% +0.020 pp | 0.01% +0.015 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 83 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11.1K +367.0 (+3.4%) | 104.0K +23.3K (+28.8%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD3.69 +154.2% | 7 qtrs — |
| 84 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 7.1K +7.1K (+100.0%) | 66.5K +66.5K (+100.0%) | 0.01% +0.013 pp | 0.00% +0.000 pp | USD9.38 +0.0% | 1 qtrs NEW |
| 85 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 6.6K +— (+0.0%) | 61.9K +12.2K (+24.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD6.17 +52.0% | 5 qtrs — |
| 86 | TOWER RESEARCH CAPITAL LLC (TRC) | 4.3K +2.3K (+118.1%) | 40.1K +25.3K (+171.7%) | 0.01% +0.004 pp | 0.00% +0.001 pp | USD6.80 +37.9% | 20 qtrs — |
| 87 | CAZ INVESTMENTS LP | 3.5K -1.5K (-30.0%) | 32.8K -4.8K (-12.8%) | 0.01% -0.003 pp | 0.06% -0.013 pp | USD3.25 +188.6% | 7 qtrs — |
| 88 | CITIGROUP INC | 3.1K +1.5K (+95.8%) | 29.2K +17.2K (+143.9%) | 0.01% +0.003 pp | 0.00% +0.000 pp | USD7.09 +32.3% | 19 qtrs — |
| 89 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 2.8K +566.0 (+25.7%) | 26.0K +9.4K (+56.6%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD6.52 +43.9% | 5 qtrs — |
| 90 | AMERITAS INVESTMENT PARTNERS, INC. | 2.6K +— (+0.0%) | 24.1K +4.8K (+24.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD19.84 -52.7% | 19 qtrs — |
| 91 | LEGAL & GENERAL GROUP PLC | 2.1K +— (+0.0%) | 19.5K +3.8K (+24.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD19.73 -52.5% | 20 qtrs — |
| 92 | NEW YORK STATE COMMON RETIREMENT FUND | 2.0K +— (+0.0%) | 19.0K +3.7K (+24.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD17.45 -46.2% | 19 qtrs — |
| 93 | PNC FINANCIAL SERVICES GROUP, INC. | 1.8K -7.0 (-0.4%) | 17.0K +3.3K (+24.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.14 +126.6% | 9 qtrs — |
| 94 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 1.5K -498.0 (-25.3%) | 13.8K -1.0K (-6.9%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD7.53 +24.6% | 19 qtrs — |
| 95 | STERLING CAPITAL MANAGEMENT LLC | 1.4K -271.0 (-16.4%) | 12.9K +507.0 (+4.1%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD6.30 +48.9% | 6 qtrs — |
| 96 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 1.2K +— (+0.0%) | 11.5K +2.3K (+24.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.86 +143.0% | 4 qtrs — |
| 97 | GF FUND MANAGEMENT CO. LTD. | 1.1K -95.0 (-7.8%) | 10.5K +1.4K (+14.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD5.75 +63.1% | 5 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 66 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Virtus Biotech Clinical Trials ETF BBC | 0.85% | 490.6K | 0.65% |
| 2 | iShares Genomics Immunology and Healthcare ETF IDNA | 0.63% | 1.23M | 0.47% |
| 3 | ALPS Medical Breakthroughs ETF SBIO | 0.49% | 1.04M | 0.50% |
| 4 | iShares Micro-Cap ETF IWC | 0.11% | 1.57M | 0.60% |
| 5 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.07% | 49.9K | 0.35% |
| 6 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.07% | 745.3K | 0.35% |
| 7 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.07% | 301.8K | 0.40% |
| 8 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.07% | 48.7K | 0.19% |
| 9 | Fidelity Enhanced Small Cap ETF FESM | 0.05% | 2.95M | 0.28% |
| 10 | iShares Biotechnology ETF IBB | 0.04% | 4.11M | 0.44% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
7
Sells
0
Shares acquired
1.64M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+1,637,500
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Shapiro David | Director | A-Award | A | Stock option (right to buy) | 60,000 | 10.64 | 638.4K | 60,000 | D | ↗ |
| 2026-01-02 | Storgard Chris | Officer | A-Award | A | Stock option (right to buy) | 250,000 | 9.10 | 2.28M | 250,000 | D | ↗ |
| 2026-01-02 | Shah Pratik | Director / Officer | A-Award | A | Stock option (right to buy) | 750,000 | 9.10 | 6.83M | 750,000 | D | ↗ |
| 2026-01-02 | Jeffries Sean | Officer | A-Award | A | Stock option (right to buy) | 375,000 | 9.10 | 3.41M | 375,000 | D | ↗ |
| 2026-01-02 | Gover Justin D. | Director | A-Award | A | Stock option (right to buy) | 45,000 | 9.10 | 409.5K | 45,000 | D | ↗ |
| 2026-01-02 | Burgess Julie | Officer | A-Award | A | Stock option (right to buy) | 150,000 | 9.10 | 1.37M | 150,000 | D | ↗ |
| 2025-12-09 | Shah Pratik | Director / Officer | A-Award | A | Stock option (right to buy) | 525,000 | 2.48 | 1.30M | 525,000 | D | ↗ |
| 2025-09-09 | Gover Justin D. | Director | A-Award | A | Stock option (right to buy) | 30,000 | 6.64 | 199.2K | 30,000 | D | ↗ |
| 2025-08-13 | William Arsani | Director | S-Sale | D | Common Stock | 345,000 | 5.25 | 1.81M | 2,655,000 | I | ↗ |
| 2025-06-10 | William Arsani | Director | A-Award | A | Stock Option (right to buy) | 19,000 | 4.01 | 76.2K | 19,000 | D | ↗ |
| 2025-06-10 | Schmid John P. | Director | A-Award | A | Stock Option (right to buy) | 19,000 | 4.01 | 76.2K | 19,000 | D | ↗ |
| 2025-06-10 | Prasad Deepa | Director | A-Award | A | Stock Option (right to buy) | 19,000 | 4.01 | 76.2K | 19,000 | D | ↗ |
| 2025-06-10 | LAPPE RODNEY W | Director | A-Award | A | Stock Option (right to buy) | 19,000 | 4.01 | 76.2K | 19,000 | D | ↗ |
| 2025-06-10 | George Simeon | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 19,000 | 4.01 | 76.2K | 19,000 | D | ↗ |
| 2025-06-10 | Berger Heather A. | Director | A-Award | A | Stock Option (right to buy) | 19,000 | 4.01 | 76.2K | 19,000 | D | ↗ |
| 2025-05-01 | Storgard Chris | Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 4.71 | 1.88M | 400,000 | D | ↗ |
| 2025-04-16 | Storgard Chris | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-01-02 | Shah Pratik | Director / Officer | A-Award | A | Stock option (right to buy) | 600,000 | 6.17 | 3.70M | 600,000 | D | ↗ |
| 2025-01-02 | LAPPE RODNEY W | Director | A-Award | A | Stock option (right to buy) | 25,993 | 6.17 | 160.4K | 25,993 | D | ↗ |
| 2025-01-02 | Jeffries Sean | Officer | A-Award | A | Stock option (right to buy) | 260,000 | 6.17 | 1.60M | 260,000 | D | ↗ |
| 2025-01-02 | Burgess Julie | Officer | A-Award | A | Stock option (right to buy) | 135,000 | 6.17 | 833.0K | 135,000 | D | ↗ |
| 2024-12-18 | Prasad Deepa | Director | S-Sale | D | Common Stock | 3,806 | 6.27 | 23.9K | 20,000 | D | ↗ |
| 2024-10-01 | DUNHAM TRUST Co | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-08-09 | William Arsani | Director | S-Sale | D | Common Stock | 814,874 | 4.25 | 3.46M | 0 | — | ↗ |
| 2024-06-13 | William Arsani | Director | A-Award | A | Stock Option (right to buy) | 19,000 | 3.82 | 72.6K | 19,000 | — | ↗ |
| 2024-06-13 | Schmid John P. | Director | A-Award | A | Stock Option (right to buy) | 19,000 | 3.82 | 72.6K | 19,000 | — | ↗ |
| 2024-06-13 | Prasad Deepa | Director | A-Award | A | Stock Option (right to buy) | 19,000 | 3.82 | 72.6K | 19,000 | — | ↗ |
| 2024-06-13 | LAPPE RODNEY W | Director | A-Award | A | Stock Option (right to buy) | 19,000 | 3.82 | 72.6K | 19,000 | — | ↗ |
| 2024-06-13 | George Simeon | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 19,000 | 3.82 | 72.6K | 19,000 | — | ↗ |
| 2024-06-13 | Berger Heather A. | Director | A-Award | A | Stock Option (right to buy) | 19,000 | 3.82 | 72.6K | 19,000 | — | ↗ |
| 2024-03-25 | Schmid John P. | Director | P-Purchase | A | Common Stock | 17,809 | 3.74 | 66.6K | 26,965 | — | ↗ |
| 2024-03-25 | Berger Heather A. | Director | P-Purchase | A | Common Stock | 1,300 | 3.74 | 4.9K | 1,300 | — | ↗ |
| 2024-03-22 | Schmid John P. | Director | P-Purchase | A | Common Stock | 9,156 | 3.62 | 33.1K | 9,156 | — | ↗ |
| 2024-03-13 | Kim Jae B. | Officer | — | D | Stock Option (right to buy) | 115,000 | 7.97 | 916.6K | 0 | — | ↗ |
| 2024-01-02 | Jeffries Sean | Officer | A-Award | A | Stock Option (right to buy) | 350,000 | 2.54 | 889.0K | 350,000 | — | ↗ |
| 2024-01-02 | Burgess Julie | Officer | A-Award | A | Stock Option (right to buy) | 110,000 | 2.54 | 279.4K | 110,000 | — | ↗ |
| 2023-12-01 | LAPPE RODNEY W | Director | A-Award | A | Stock Option (right to buy) | 69,186 | 2.51 | 173.7K | 69,186 | — | ↗ |
| 2023-12-01 | Ansari Aseem Z. | 10% Owner | A-Award | A | Stock Option (right to buy) | 100,000 | 2.51 | 251.0K | 100,000 | — | ↗ |
| 2023-09-29 | LAPPE RODNEY W | Director | P-Purchase | A | Common Stock | 21,000 | 2.35 | 49.3K | 133,024 | — | ↗ |
| 2023-09-01 | Shah Pratik | Director / Officer | A-Award | A | Stock Option (right to buy) | 1,050,000 | 2.48 | 2.60M | 1,050,000 | — | ↗ |
| 2023-08-29 | William Arsani | Director | P-Purchase | A | Common Stock | 1,960,000 | 2.44 | 4.78M | 3,000,000 | — | ↗ |
| 2023-08-29 | Prasad Deepa | Director | P-Purchase | A | Common Stock | 12,000 | 2.31 | 27.7K | 23,806 | — | ↗ |
| 2023-08-28 | William Arsani | Director | P-Purchase | A | Common Stock | 275,000 | 2.15 | 591.3K | 1,040,000 | — | ↗ |
| 2023-05-31 | Xu Stella | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 5.63 | 84.5K | 15,000 | — | ↗ |
| 2023-05-31 | William Arsani | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 5.63 | 84.5K | 15,000 | — | ↗ |
| 2023-05-31 | Schmid John P. | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 5.63 | 84.5K | 15,000 | — | ↗ |
| 2023-05-31 | Prasad Deepa | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 5.63 | 84.5K | 15,000 | — | ↗ |
| 2023-05-31 | LAPPE RODNEY W | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 5.63 | 84.5K | 15,000 | — | ↗ |
| 2023-05-31 | George Simeon | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 15,000 | 5.63 | 84.5K | 15,000 | — | ↗ |
| 2023-05-31 | Berger Heather A. | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 5.63 | 84.5K | 15,000 | — | ↗ |
| 2023-02-01 | Siffert Joao MD | Director / Officer | A-Award | A | Stock Option (right to buy) | 415,000 | 7.97 | 3.31M | 415,000 | — | ↗ |
| 2023-02-01 | Shah Pratik | Director / Officer | A-Award | A | Stock Option (right to buy) | 415,000 | 7.97 | 3.31M | 415,000 | — | ↗ |
| 2023-02-01 | Jeffries Sean | Officer | A-Award | A | Stock Option (right to buy) | 140,000 | 7.97 | 1.12M | 140,000 | — | ↗ |
| 2023-02-01 | Burgess Julie | Officer | A-Award | A | Stock Option (right to buy) | 75,000 | 7.97 | 597.8K | 75,000 | — | ↗ |
| 2022-12-20 | Siffert Joao MD | Officer | P-Purchase | A | Common Stock | 6,300 | 8.38 | 52.8K | 132,619 | — | ↗ |
| 2022-12-20 | SR One Capital Fund I Aggregator LP | Director | P-Purchase | A | Common Stock | 40,000 | 8.14 | 325.4K | 6,526,476 | — | ↗ |
| 2022-12-20 | George Simeon | Director | P-Purchase | A | Common Stock | 40,000 | 8.14 | 325.4K | 6,526,476 | — | ↗ |
| 2022-12-19 | Siffert Joao MD | Officer | P-Purchase | A | Common Stock | 1,150 | 8.47 | 9.7K | 126,319 | — | ↗ |
| 2022-12-19 | SR One Capital Fund I Aggregator LP | Director | P-Purchase | A | Common Stock | 360,000 | 8.63 | 3.11M | 6,486,476 | — | ↗ |
| 2022-12-19 | George Simeon | Director | P-Purchase | A | Common Stock | 360,000 | 8.63 | 3.11M | 6,486,476 | — | ↗ |
| 2022-12-16 | SR One Capital Fund I Aggregator LP | Director | P-Purchase | A | Common Stock | 500,000 | 8.28 | 4.14M | 6,126,476 | — | ↗ |
| 2022-12-16 | George Simeon | Director | P-Purchase | A | Common Stock | 500,000 | 8.28 | 4.14M | 6,126,476 | — | ↗ |
| 2022-12-09 | LAPPE RODNEY W | Director | P-Purchase | A | Common Stock | 15,000 | 7.96 | 119.4K | 112,024 | — | ↗ |
| 2022-06-15 | Xu Stella | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-06-15 | William Arsani | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-06-15 | Schmid John P. | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-06-15 | Prasad Deepa | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-06-15 | LAPPE RODNEY W | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-06-15 | George Simeon | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-06-15 | Berger Heather A. | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 13.69 | 205.4K | 15,000 | — | ↗ |
| 2022-03-21 | William Arsani | Director | P-Purchase | A | Common Stock | 25,000 | 18.99 | 474.7K | 2,797,501 | — | ↗ |
| 2022-03-18 | Xu Stella | Director | S-Sale | D | Common Stock | 13,200 | 20.34 | 268.5K | 4,155,405 | — | ↗ |
| 2022-03-16 | Prasad Deepa | Director | J-Other | A | Common Stock | 11,806 | 0.00 | — | 11,806 | — | ↗ |
| 2022-02-01 | Siffert Joao MD | Director / Officer | A-Award | A | Stock Option (right to buy) | 475,000 | 12.77 | 6.07M | 475,000 | — | ↗ |
| 2022-02-01 | Shah Pratik | Director / Officer | A-Award | A | Stock Option (right to buy) | 475,000 | 12.77 | 6.07M | 475,000 | — | ↗ |
| 2022-02-01 | Jeffries Sean | Officer | A-Award | A | Stock Option (right to buy) | 350,000 | 12.77 | 4.47M | 350,000 | — | ↗ |
| 2022-02-01 | Burgess Julie | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 12.77 | 638.5K | 50,000 | — | ↗ |
| 2021-10-01 | Burgess Julie | Officer | A-Award | A | Stock Option (right to buy) | 135,000 | 14.99 | 2.02M | 135,000 | — | ↗ |
| 2021-09-13 | Burgess Julie | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-08-31 | William Arsani | Director | P-Purchase | A | Common Stock | 40,000 | 15.45 | 618.0K | 2,772,501 | — | ↗ |
| 2021-08-13 | Giangiulio Dawn | Officer | — | D | Stock option (right to buy) | 24,539 | 0.95 | 23.3K | 0 | — | ↗ |
| 2021-06-15 | Prasad Deepa | Director | — | I | Common Stock | 0 | 0.00 | — | 337,327 | — | ↗ |
| 2021-06-15 | Behanna Heather | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 27.04 | 811.2K | 30,000 | — | ↗ |
| 2021-03-30 | Xu Stella | Director / 10% Owner | C-Conversion | D | Series B Preferred Stock | 458,016 | 0.00 | — | 0 | — | ↗ |
| 2021-03-30 | William Arsani | Director | P-Purchase | A | Common Stock | 700,000 | 20.00 | 14.00M | 2,732,501 | — | ↗ |
| 2021-03-30 | Thacker Justin | Officer | P-Purchase | A | Common Stock | 17,500 | 20.00 | 350.0K | 17,500 | — | ↗ |
| 2021-03-30 | Shah Pratik | Officer | C-Conversion | A | Common Stock | 104,923 | — | — | 129,923 | — | ↗ |
| 2021-03-30 | SR One Capital Fund I Aggregator LP | 10% Owner | C-Conversion | A | Common Stock | 4,439,839 | 0.00 | — | 4,439,839 | — | ↗ |
| 2021-03-30 | Quan Venture Fund II, L.P. | 10% Owner | C-Conversion | A | Common Stock | 280,991 | 0.00 | — | 4,720,830 | — | ↗ |
| 2021-03-30 | LAPPE RODNEY W | Director | P-Purchase | A | Common Stock | 5,000 | 20.00 | 100.0K | 97,024 | — | ↗ |
| 2021-03-30 | Jeffries Sean | Officer | P-Purchase | A | Common Stock | 3,050 | 20.00 | 61.0K | 3,050 | — | ↗ |
| 2021-03-30 | George Simeon | Director / 10% Owner | C-Conversion | D | Series A Preferred Stock | 7,236,938 | 0.00 | — | 0 | — | ↗ |
| 2021-03-30 | Cormorant Asset Management, LP | — | P-Purchase | A | Common Stock | 750,000 | 20.00 | 15.00M | 5,114,844 | — | ↗ |
| 2021-03-25 | Xu Stella | Director / 10% Owner | — | I | Series A Preferred Stock | 4,439,839 | 0.00 | — | 0 | — | ↗ |
| 2021-03-25 | William Arsani | Director | — | I | Series B Preferred Stock | 814,874 | 0.00 | — | 0 | — | ↗ |
| 2021-03-25 | Thacker Justin | Officer | — | D | Stock option (right to buy) | 92,024 | 0.95 | 87.4K | 0 | — | ↗ |
| 2021-03-25 | Star Irrevocable Trust #1 dated April 22, 2019 | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 3,834,355 | — | ↗ |
| 2021-03-25 | Siffert Joao MD | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 122,699 | — | ↗ |
| 2021-03-25 | Shah Pratik | Director / Officer | — | I | Series A Preferred Stock | 104,923 | 0.00 | — | 0 | — | ↗ |
| 2021-03-25 | Schmid John P. | Director | — | D | Common Stock | 0 | 0.00 | — | 30,674 | — | ↗ |
| 2021-03-25 | SR One Capital Fund I Aggregator LP | 10% Owner | — | — | Series B Preferred Stock | 936,637 | 0.00 | — | 0 | D | ↗ |
| 2021-03-25 | Light Irrevocable Trust #1 dated April 22, 2019 | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 3,834,355 | — | ↗ |
| 2021-03-25 | LAPPE RODNEY W | Director | — | D | Common Stock | 0 | 0.00 | — | 92,024 | — | ↗ |
| 2021-03-25 | Jeffries Sean | Officer | — | D | Common Stock | 0 | 0.00 | — | 807,233 | — | ↗ |
| 2021-03-25 | George Simeon | Director / 10% Owner | — | I | Series B Preferred Stock | 936,637 | 0.00 | — | 0 | — | ↗ |
| 2021-03-25 | Cormorant Asset Management, LP | 10% Owner | — | I | Series B Convertible Preferred Stock | 1,404,953 | 0.00 | — | 0 | — | ↗ |
| 2021-03-25 | Ansari Aseem Z. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 7,668,711 | — | ↗ |
| 2020-10-12 | Siffert Joao MD | Director / Officer | — | D | Stock option (right to buy) | 644,171 | 0.95 | 612.0K | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
62.46M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Pratik Shah, Ph.D. President, Chief Executive Officer and Chairperson | 395.0K | 144.0K | — | 2.75M | 237.0K | 14.0K | 3.54M | 77.71% | ↗ |
| 2 | 2025 | Chris M. Storgard, M.D. Chief Medical Officer | 339.3K | 144.7K | — | 1.40M | 135.7K | 14.0K | 2.03M | 68.81% | ↗ |
| 3 | 2025 | Sean Jeffries, Ph.D. Chief Operating Officer | 484.0K | 6.4K | — | 1.19M | 193.6K | 14.0K | 1.89M | 63.10% | ↗ |
| 4 | 2024 | Sean Jeffries, Ph.D. Chief Operating Officer | 432.7K | 26.9K | — | 668.5K | 173.1K | 13.9K | 1.32M | 50.84% | ↗ |
| 5 | 2024 | Pratik Shah, Ph.D. President, Chief Executive Officer and Chairperson | 395.0K | 144.0K | — | — | 237.0K | 13.8K | 789.8K | 0.00% | ↗ |
| 6 | 2024 | Jae B. Kim, M.D. Former Chief Medical Officer | 362.7K | — | — | 334.3K | — | 13.7K | 710.7K | 47.03% | ↗ |
| 7 | 2023 | Pratik Shah, Ph.D. President, Chief Executive Officer and Chairperson | 360.6K | 181.6K | — | 5.61M | 148.7K | 13.2K | 6.32M | 88.86% | ↗ |
| 8 | 2023 | João Siffert, M.D. Former President and Chief Executive Officer | 431.4K | — | — | 2.19M | — | 893.9K | 3.51M | 62.27% | ↗ |
| 9 | 2023 | Sean Jeffries, Ph.D. Chief Operating Officer | 416.0K | — | — | 729.6K | 124.8K | 13.2K | 1.28M | 56.84% | ↗ |
| 10 | 2022 | João Siffert, M.D. Former President and Chief Executive Officer | 577.5K | — | — | 3.88M | 288.8K | 36.2K | 4.78M | 81.12% | ↗ |
| 11 | 2022 | João Siffert, M.D. President and Chief Executive Officer | 577.5K | — | — | 3.88M | 288.8K | 36.2K | 4.78M | 81.12% | ↗ |
| 12 | 2022 | Pratik Shah, Ph.D. Executive Chairperson | 337.5K | 120.0K | — | 3.88M | 168.8K | 12.2K | 4.52M | 85.86% | ↗ |
| 13 | 2022 | Pratik Shah, Ph.D. President, Chief Executive Officer and Chairperson | 337.5K | 120.0K | — | 3.88M | 168.8K | 12.2K | 4.52M | 85.86% | ↗ |
| 14 | 2022 | Sean Jeffries, Ph.D. Chief Operating Officer | 400.0K | — | — | 2.86M | 160.0K | 12.2K | 3.43M | 83.31% | ↗ |
| 15 | 2021 | João Siffert, M.D. President and Chief Executive Officer | 550.0K | 150.0K | — | — | 275.0K | 18.0K | 933.0K | 0.00% | ↗ |
| 16 | 2021 | Pratik Shah, Ph.D. Executive Chairperson | 310.0K | 120.0K | — | — | 155.0K | — | 585.0K | 0.00% | ↗ |
| 17 | 2021 | Sean Jeffries, Ph.D. Chief Operating Officer | 340.0K | — | — | — | 136.0K | — | 476.0K | 0.00% | ↗ |
| 18 | 2020 | João Siffert, M.D. President and Chief Executive Officer | 122.9K | — | — | 4.23M | — | — | 4.36M | 97.18% | ↗ |
| 19 | 2020 | Pratik Shah, Ph.D. Executive Chairperson | 250.0K | — | — | — | 150.0K | — | 400.0K | 0.00% | ↗ |
| 20 | 2020 | Sean Jeffries, Ph.D. Chief Operating Officer | 243.3K | — | — | — | 100.0K | — | 343.3K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Pratik Shah | Co-Founder, President, Chief Executive Officer, Principal Financial Officer & Executive Chairperson | 790.0K | male |
| Sean Jeffries | Chief Operating Officer | 698.0K | — |
| Chris Storgard | Chief Medical Officer | 633.8K | — |
| Jim Kerr | Chief of Manufacturing & Product Development | — | male |
| Julie D. Burgess | Chief Accounting Officer | — | female |
| Mustapha Parekh | General Counsel | — | male |
| Aseem Z. Ansari | Co-Founder & Scientific Advisor | — | — |
| Tadimeti S. Rao | Chief Scientific Officer | — | — |
| Chengzhi Zhang | Chief Chemist | — | — |
| Doane Chilcoat | Chief Technology Officer | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DSGN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
